Want to see AVAH full AI Analyst Report?
AVAH Stock Chart & Stats
$13.62
$0.37(4.07%)
At close: 4:00 PM EDT
$13.62
$0.37(4.07%)
Day’s Range― - ―
52-Week Range$5.93 - $14.71
Previous CloseN/A
Volume2.96M
Average Volume (3M)3.77M
Market Cap
$2.70B
Enterprise Value$3.45K
Total Cash (Recent Filing)$97.20M
Total Debt (Recent Filing)$1.51B
Price to Earnings (P/E)9.3
Beta1.24
Next Earnings
Nov 05, 2026EPS Estimate
0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.33
Shares Outstanding218,290,680
10 Day Avg. Volume3,468,867
30 Day Avg. Volume3,766,254
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)8.46
Price to Sales (P/S)0.68
P/FCF Ratio14.33
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$14.86Price Target Upside9.08% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
EPS Forecast (FY)0.82
Revenue Forecast (FY)$2.69B
Bulls Say, Bears Say
Bulls Say
Raised Guidance And Broad-based GrowthHigher guidance following strong quarterly growth indicates improving demand and execution across Aveanna’s care and medical solutions offerings. If management delivers against its upgraded targets, greater scale should support reinvestment, strengthen payer relationships, and improve the durability of earnings growth.
Strengthening Cash Generation And LiquidityPositive and improving free cash flow gives Aveanna internal funding for operations, integration, and selective growth while reducing reliance on external capital. Substantial liquidity also provides a buffer against reimbursement timing, labor investments, and other execution needs over the next several quarters.
Payer Traction And Structural Reimbursement SupportExpanded preferred-payer coverage and state rate enhancements can improve access to reimbursed demand and support clinician economics over time. The California PDN investment may further aid recruitment and retention, while payer scale can make revenue growth and care coordination more durable.
Bears Say
High Leverage And Thin Equity CushionAveanna’s debt-heavy capital structure leaves limited equity protection if operating performance weakens or integration costs rise. Although much variable-rate debt is hedged and management targets sub-3x net leverage, the current burden can restrict capital allocation and make deleveraging a multiyear task.
Caregiver Labor Constraints And Wage PressureCaregiver availability directly limits Aveanna’s capacity to accept patients and convert demand into revenue. Required wage pass-throughs and hiring investments can also compress margins before reimbursement catches up, making sustained growth dependent on continued improvements in recruitment, retention, and labor productivity.
Acquisition Integration Execution RiskThe ongoing integration creates execution risk during a period when Aveanna is also pursuing organic growth and deleveraging. Delays in back-office or EMR transitions could create temporary costs, disrupt operating consistency, and postpone expected benefits from the acquisition’s expanded Florida and rural-market presence.
Aveanna Healthcare Holdings News
AVAH FAQ
What was Aveanna Healthcare Holdings’s price range in the past 12 months?
Aveanna Healthcare Holdings lowest stock price was $5.93 and its highest was $14.71 in the past 12 months.
What is Aveanna Healthcare Holdings’s market cap?
Aveanna Healthcare Holdings’s market cap is $2.70B.
When is Aveanna Healthcare Holdings’s upcoming earnings report date?
Aveanna Healthcare Holdings’s upcoming earnings report date is Nov 05, 2026 which is in 40 days.
How were Aveanna Healthcare Holdings’s earnings last quarter?
Aveanna Healthcare Holdings released its earnings results on Aug 13, 2026. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.168 by $0.052.
Is Aveanna Healthcare Holdings overvalued?
According to Wall Street analysts Aveanna Healthcare Holdings’s price is currently Undervalued.
Does Aveanna Healthcare Holdings pay dividends?
Aveanna Healthcare Holdings does not currently pay dividends.
What is Aveanna Healthcare Holdings’s EPS estimate?
Aveanna Healthcare Holdings’s EPS estimate is 0.21.
How many shares outstanding does Aveanna Healthcare Holdings have?
Aveanna Healthcare Holdings has 218,290,680 shares outstanding.
What happened to Aveanna Healthcare Holdings’s price movement after its last earnings report?
Aveanna Healthcare Holdings reported an EPS of $0.22 in its last earnings report, beating expectations of $0.168. Following the earnings report the stock price went up 24.751%.
Which hedge fund is a major shareholder of Aveanna Healthcare Holdings?
Currently, no hedge funds are holding shares in AVAH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Aveanna Healthcare Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$14.86 (9.08% Upside)
$14.86 (9.08% Upside)
Blogger Sentiment
Bullish
AVAH Sentiment 91%
Sector Average 63%
Sector Average 63%
Hedge Fund Trend
Increased
By 538.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $647.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.6%
Last 30 Days ▲ 15.9%
Last 30 Days ▲ 15.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
46.69%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
18.94%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Aveanna Healthcare Holdings
Aveanna Healthcare Holdings Inc. operates as a diverse platform for home-based care services throughout the United States. The company delivers a range of critical offerings, including private duty nursing (PDN), adult home health and hospice care, in-home pediatric therapy, and enteral nutrition services. Its patient-centered approach allows individuals to receive essential medical care within their own homes, effectively reducing the need for costly institutional settings such as hospitals. The company's operations are structured into three key segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment provides specialized private duty nursing, which includes skilled nursing care for medically fragile children at home, nursing support in school environments, and services at pediatric day healthcare centers. This segment also offers employer-of-record support, personal care services, and pediatric therapy (physical, occupational, and speech) provided both in clinics and patients' residences. The HHH segment focuses on home health services, encompassing in-home skilled nursing, physical, occupational, and speech therapy, as well as medical social work and aide assistance. Furthermore, it delivers hospice services, offering compassionate care to patients and their families when life-limiting illnesses no longer respond to curative treatments. The MS segment supplies enteral nutrition products and other vital medical supplies to adults and children, distributed on either a scheduled or as-needed basis. Founded in 2016, Aveanna Healthcare Holdings Inc. is headquartered in Atlanta, Georgia.
AVAH Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveys a clear recovery and momentum: strong revenue and adjusted EBITDA growth, raised full‑year guidance, improved payer and government engagements (including a major California PDN budget win), positive cash generation, and preferred‑payer traction across segments. Primary risks are operational — caregiver labor constraints, short‑term wage pass‑throughs that can pressure margins, integration and timing risks (notably final California rate details) and a sizable but largely hedged debt position. Overall, the positives (accelerating organic growth, guidance raise, liquidity, payer wins and structural rate improvements) materially outweigh the manageable execution and timing headwinds.View all AVAH earnings summariesAVAH Stock 12 Month Forecast
Average Price Target
$14.86
▲(9.08% Upside)
Technical Analysis
Ownership Overview
43.25% Insiders
6.51% Mutual Funds
17.12% Other Institutional Investors
26.48% Public Companies and
Individual Investors